X 4 Pharmaceuticals Inc (XFOR)

X 4 Pharmaceuticals Inc (XFOR) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	47.98% 37.29	25.20	27.21	25.80	29.30
Interest Income/Expense	0.64% 1.874	1.886	1.634	1.148	1.109
Operating Income/Loss	47.98% -37.29	-25.20	-27.21	-25.80	-29.30
Nonoperating Income/Loss	336.94% -14.46	6.102	24.93	-29.89	5.288
Income/Loss From Continuing Operations Before Tax	170.97% -51.75	-19.10	-2.279	-55.70	-24.02
Income Tax Expense/Benefit	42.42% 0.019	0.033	0.026	0.015	0.004
Income/Loss From Continuing Operations After Tax	170.60% -51.77	-19.13	-2.305	-55.71	-24.02
Net Income/Loss	170.60% -51.77	-19.13	-2.305	-55.71	-24.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,732% 199.99	7.0615	196.99	168.74	145.97
Diluted Average Shares	2,732% 199.99	7.0615	196.99	168.74	145.97
Basic Earnings Per Share	188.89% -0.26	-0.09	-0.01	-0.33	-0.16
Diluted Earnings Per Share	188.89% -0.26	-0.09	-0.01	-0.33	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-